Why You Should Pass On Investing In This $3.00 Drug Stock
November 03, 2015 at 12:19 PM EST
I dived in deeper myself before making any decision to recommend this company as a holding. Catalyst Pharmaceuticals (CPRX) goes for just over $3.00 a share and has been getting some positive attention from analysts recently.
